Publicaciones en las que colabora con Vladimir Rosa Salazar (27)

2023

  1. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations

    British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981

2022

  1. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry

    Viruses, Vol. 14, Núm. 2

2018

  1. Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry

    Journal of Thrombosis and Thrombolysis, Vol. 46, Núm. 4, pp. 551-558

  2. Early use of echocardiography in patients with acute pulmonary embolism: Findings from the RIETE registry

    Journal of the American Heart Association, Vol. 7, Núm. 17

  3. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

    Clinical Pharmacology and Therapeutics, Vol. 103, Núm. 4, pp. 684-691

  4. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

    American Journal of Medicine, Vol. 131, Núm. 4, pp. 430-437

2017

  1. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

    Journal of Vascular Surgery: Venous and Lymphatic Disorders

  2. Corrigendum to ‘Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism’ American Journal of Medicine 130(5)(2017): 588-595 (S0002934316312414)(10.1016/j.amjmed.2016.11.027)

    American Journal of Medicine

  3. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

    Chest, Vol. 151, Núm. 3, pp. 564-571

  4. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

    American Journal of Medicine, Vol. 130, Núm. 4, pp. 482.e1-482.e9

  5. Predictors of active cancer thromboembolic outcomes: RIETE experience of the Khorana score in cancer-associated thrombosis

    Thrombosis and Haemostasis, Vol. 117, Núm. 6, pp. 1192-1198

  6. Prognostic Significance of Right Heart Thrombi in Patients With Acute Symptomatic Pulmonary Embolism: Systematic Review and Meta-analysis

    Chest, Vol. 151, Núm. 2, pp. 409-416

  7. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

    American Journal of Medicine, Vol. 130, Núm. 3, pp. 337-347

  8. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

    American Journal of Medicine, Vol. 130, Núm. 5, pp. 588-595

2016

  1. DVT Management and Outcome Trends, 2001 to 2014

    Chest, Vol. 150, Núm. 2, pp. 374-383

  2. Right heart thrombi in pulmonary embolism

    European Respiratory Journal, Vol. 48, Núm. 5, pp. 1377-1385

2015

  1. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs

    American Journal of Medicine, Vol. 128, Núm. 1, pp. 90.e9-90.e15

  2. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity

    Journal of Thrombosis and Haemostasis, Vol. 13, Núm. 7, pp. 1274-1278

  3. Fatal events in cancer patients receiving anticoagulant therapy for venous thromboembolism

    Medicine (United States), Vol. 94, Núm. 32

  4. Fondaparinux in the initial and long-term treatment of venous thromboembolism

    Thrombosis Research, Vol. 135, Núm. 2, pp. 311-317